| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Monopar Therapeutics Inc.: Monopar Announces CFO Succession | 86 | GlobeNewswire (Europe) | WILMETTE, Ill., May 24, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharmaceutical company focused on developing innovative treatments for cancer patients... ► Artikel lesen | |
| 09.05. | Monopar Therapeutics Inc.: Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline | 122 | GlobeNewswire (Europe) | Initiated MNPR-101-Zr First-in-Human Phase 1 Radiopharma Clinical Trial MNPR-101-RIT Phase 1 Clinical Trial Targeted for Launch as Early as Q4 2024 or Q1 2025 WILMETTE, Ill., May 09, 2024 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| 18.04. | Monopar Therapeutics Inc.: Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting | 2 | GlobeNewswire (USA) | ||
| 10.04. | Monopar Therapeutics Inc.: Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients | 396 | GlobeNewswire (Europe) | WILMETTE, Ill., April 10, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients... ► Artikel lesen | |
| 28.03. | Monopar Therapeutics Inc reports results for the quarter ended in December - Earnings Summary | 3 | Reuters | ||
| 28.03. | Monopar Therapeutics Inc.: Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments | 84 | GlobeNewswire (Europe) | WILMETTE, Ill., March 28, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients... ► Artikel lesen | |
| 05.03. | Monopar Therapeutics Inc.: Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program | 137 | GlobeNewswire (Europe) | WILMETTE, Ill., March 05, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients... ► Artikel lesen | |
| 27.02. | Monopar Therapeutics Inc.: Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial | 277 | GlobeNewswire (Europe) |
WILMETTE, Ill., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients... ► Artikel lesen | |
| 20.02. | Monopar Therapeutics Inc.: Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers | 310 | GlobeNewswire (Europe) | WILMETTE, Ill., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 1.231 |
| NEL | 1.150 |
| EVOTEC | 1.111 |
| GAMESTOP | 1.067 |
| TUI | 726 |
| BAYER | 560 |
| BIONTECH | 464 |
| RHEINMETALL | 382 |
| PLUG POWER | 368 |
| SUPER MICRO COMPUTER | 320 |
| BYD | 309 |
| COMMERZBANK | 307 |
| DEUTSCHE LUFTHANSA | 295 |
| TESLA | 287 |
| SIEMENS ENERGY | 277 |
| DEUTSCHE BANK | 275 |
| MERCEDES-BENZ | 265 |
| VOLKSWAGEN | 263 |
| AIXTRON SE | 228 |
| ALLIANZ | 203 |
| THYSSENKRUPP | 199 |
| BASF | 198 |
| ADLER GROUP | 195 |
| RWE | 191 |
| AMC ENTERTAINMENT | 189 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
